Patent details

EP3678649 Title: INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3678649
WO Application Number:
US2019016918
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19751807.9
WO Publication Number:
WO2019157099
EPO Publication Language:
English
SPC Number:
301317
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
06/02/2019
Grant date:
26/10/2022
EP Publication Date:
15/07/2020
WO Publication Date:
15/08/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/01/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
26/10/2022
EP B1 Publication Date:
26/10/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/02/2039
Lapsed By Expiration Date:
Patent Validated Date:
17/01/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/11/2023
 
 

 

Name:
Aegis Therapeutics, LLC
Address:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, United States of America (US)

From:
17/11/2023
 
 

 

Name:
ARS Pharmaceuticals Operations, Inc.
Address:
11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)

Historical Applicant/holder

From:
17/11/2023
To:
17/11/2023

 

Name:
Aegis Therapeutics, LLC
Address:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, United States of America (US)

From:
17/11/2023
To:
17/11/2023

 

Name:
ARS subsidiary, Inc.
Address:
11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)

From:
26/10/2022
To:
17/11/2023

 

Name:
Aegis Therapeutics, LLC
Address:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, United States of America (US)

From:
26/10/2022
To:
17/11/2023

 

Name:
ARS Pharmaceuticals Inc.
Address:
11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)

Agent

Name:
dr. R.C. van Duijvenbode c.s.
From:
13/01/2023
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
LOWENTHAL, Richard
Address:
San Diego, California 92127, United States of America (US)

2

Name:
MAGGIO, Edward T.
Address:
San Diego, California 92121, United States of America (US)

3

Name:
BELL, Robert G.
Address:
San Diego, California 92127, United States of America (US)

4

Name:
SHAH, Pratik
Address:
San Diego, California 92127, United States of America (US)

Priority

1

Priority Patent Number:
201862734550 P
Priority Date:
21/09/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201862685049 P
Priority Date:
14/06/2018
Priority Country:
United States of America (US)

3

Priority Patent Number:
201862784057 P
Priority Date:
21/12/2018
Priority Country:
United States of America (US)

4

Priority Patent Number:
201815890131
Priority Date:
06/02/2018
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/137; A61K 9/08; A61K 47/26; A61P 27/14;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
47/23
Publication date:
22/11/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
47/23
Publication date:
22/11/2023
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
03/23
Publication date:
18/01/2023
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
43/22
Publication date:
26/10/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202251
Publication date:
21/12/2022
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
202247
Publication date:
23/11/2022
Description:
Designated states changed

3

Issue number:
202246
Publication date:
16/11/2022
Description:
Document reprinted after correction (B8, B9)

4

Issue number:
202245
Publication date:
09/11/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

5

Issue number:
202243
Publication date:
26/10/2022
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202302305A
Date Registered:
17/11/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Aegis Therapeutics, LLC
Address:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, United States of America (US)

2

Name:
ARS Subsidiary, Inc.
Address:
11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202302305B
Date Registered:
17/11/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Aegis Therapeutics, LLC
Address:
3430 Carmel Mountain Road, Suite 300, San Diego CA 92121, United States of America (US)

2

Name:
ARS Pharmaceuticals Operations, Inc.
Address:
11682 El Camino Real, Suite 120, 92130, San Diego, California, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
28/02/2026
Annual Fee Number:
8
Annual Fee Amount:
280 Euro
Last Annual Payment Date:
27/02/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
220 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date Document type Document Description Number of pages File Type
16/01/2023 Outgoing Correspondence Letter no formal defects 1 PDF /8/9/9/1/3/0800831998/docs/ep19751807.9_0_526170l271.pdf
11/01/2023 Claims First filed claims 3 PDF /8/9/9/1/3/0800831998/docs/ep19751807.9_1_claims20230111084542159.pdf